![Eun-Seok Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 3 M $ al 30/09/2026
Eun-Seok Kim formerly worked at RedoxBio Co., Ltd., as Director.
Mr. Kim received his undergraduate degree and graduate degree from Sungkyunkwan University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
DAE HWA PHARM CO., LTD. 1,25 % | 18/09/2026 | 232.100 ( 1,25 % ) | 2 M $ | 30/09/2026 |
RedoxBio Co., Ltd.
 RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells sodium hyaluronate 2,56 % | 30/09/2025 | 631.260 ( 2,56 % ) | 2 M $ | 31/12/2020 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DAE HWA PHARMACEUTICAL CO., LTD. | Director Ejecutivo | 20/03/2015 |
| Empresas | Cargo | Fin |
|---|---|---|
RedoxBio Co., Ltd.
RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells sodium hyaluronate | Director/Miembro de la Junta | 31/05/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
DAE HWA PHARM Co., Ltd.
 DAE HWA PHARM Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sungkyunkwan University
 Sungkyunkwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RedoxBio Co., Ltd.
RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells sodium hyaluronate | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
